T. Rowe Price Associates’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

T. Rowe Price Associates’s Portfolio CMAX Stock Details CMAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,986	Closed	-$45K	–	3019
2023 Q4	$45K	Buy	2,986 +82	+3%	+$3.4K	﹤0.01%	2825
2023 Q3	$185K	Buy	2,904 +434	+18%	+$30.4K	﹤0.01%	2527
2023 Q2	$231K	Buy	2,470 +181	+8%	+$15.9K	﹤0.01%	2475
2023 Q1	$184K	Buy	2,289 +1,034	+82%	+$121K	﹤0.01%	2553
2022 Q4	$137K	Buy	1,255 +386	+44%	+$57.7K	﹤0.01%	2647
2022 Q3	$185K	Buy	869 +119	+16%	+$24K	﹤0.01%	2575
2022 Q2	$82K	Buy	+750	New	+$129K	﹤0.01%	2800
2021 Q2	–	Sell	-3,158	Closed	-$1.15M	–	2998
2021 Q1	$1.15M	Buy	+3,158	New	+$1.33M	﹤0.01%	1995

Other funds holding CMAX

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates's CMAX Position: Q1 2024 in Review

T. Rowe Price Associates sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q1 2024, closing a stake of 2,986 shares — an estimated $45K sold.

T. Rowe Price Associates first reported a position in CMAX in Q1 2021 and held it in 8 quarters. The position peaked at $1.15M in Q1 2021. 42 funds tracked by Wall St. Rank hold CMAX as of Q1 2024.

T. Rowe Price Associates reported no remaining CareMax, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
T. Rowe Price Associates sold 2,986 CareMax, Inc. Class A Common Stock shares in Q1 2024, an estimated $45K.
T. Rowe Price Associates first reported a position in CareMax, Inc. Class A Common Stock in Q1 2021 and held it in 8 quarters.
T. Rowe Price Associates's CareMax, Inc. Class A Common Stock position peaked at $1.15M in Q1 2021.
42 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q1 2024.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.